Total Payments
$17,292
2024 Payments
$955.46
Companies
21
Transactions
95
Medicare Patients
372
Medicare Billing
$137,036
Payment Breakdown by Category
Other$12,420 (71.8%)
Food & Beverage$2,929 (16.9%)
Education$1,156 (6.7%)
Consulting$787.50 (4.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,420 | 9 | 71.8% |
| Food and Beverage | $2,929 | 63 | 16.9% |
| Education | $1,156 | 19 | 6.7% |
| Consulting Fee | $787.50 | 4 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $5,483 | 29 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $5,126 | 5 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $3,899 | 11 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $592.35 | 18 | $0 (2024) |
| Fisher & Paykel Healthcare Inc | $488.56 | 3 | $0 (2023) |
| Abbott Laboratories | $460.65 | 3 | $0 (2019) |
| Outset Medical Inc | $242.22 | 1 | $0 (2024) |
| Medtronic Vascular, Inc. | $218.58 | 2 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $113.88 | 1 | $0 (2023) |
| One Lambda, Inc. | $100.61 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $955.46 | 16 | Astellas Pharma US Inc ($333.69) |
| 2023 | $830.02 | 10 | Fisher & Paykel Healthcare Inc ($488.56) |
| 2022 | $196.49 | 2 | Astellas Pharma US Inc ($196.49) |
| 2021 | $266.70 | 4 | Astellas Pharma US Inc ($157.50) |
| 2020 | $854.21 | 8 | Astellas Pharma US Inc ($778.99) |
| 2019 | $244.62 | 2 | Medtronic Vascular, Inc. ($131.19) |
| 2018 | $296.84 | 5 | Astellas Pharma US Inc ($150.95) |
| 2017 | $13,648 | 48 | Bayer HealthCare Pharmaceuticals Inc. ($5,126) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $76.65 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Eurofins Viracor, LLC | — | Food and Beverage | In-kind items and services | $50.65 | General |
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $36.24 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2024 | SANOFI PASTEUR INC. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: Immunology | ||||||
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | One Lambda, Inc. | — | Food and Beverage | Cash or cash equivalent | $100.61 | General |
| 05/15/2024 | Outset Medical Inc | — | Food and Beverage | In-kind items and services | $242.22 | General |
| 05/09/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $122.16 | General |
| Category: Infectious Diseases | ||||||
| 04/19/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $75.00 | General |
| 04/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: IMMUNOLOGY | ||||||
| 04/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: IMMUNOLOGY | ||||||
| 04/03/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $59.99 | General |
| 04/03/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $44.99 | General |
| 03/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: RESPIRATORY | ||||||
| 03/20/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $31.55 | General |
| Category: Infectious Diseases | ||||||
| 10/19/2023 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $151.20 | General |
| Category: Nasal High Flow | ||||||
| 10/04/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $89.99 | General |
| 10/04/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $75.00 | General |
| 09/14/2023 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: Infectious Diseases | ||||||
| 08/15/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: EXALT_ENDO | ||||||
| 07/25/2023 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $186.58 | General |
| Category: Nasal High Flow | ||||||
| 07/11/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: EXALT_ENDO | ||||||
| 05/31/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $113.88 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2023 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $150.78 | General |
| Category: Nasal High Flow | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 156 | 496 | $185,375 | $46,157 |
| 2022 | 4 | 104 | 334 | $125,874 | $29,822 |
| 2021 | 2 | 59 | 296 | $121,314 | $30,194 |
| 2020 | 2 | 53 | 330 | $135,270 | $30,862 |
Total Patients
372
Total Services
1,456
Medicare Billing
$137,036
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 56 | 134 | $57,486 | $16,231 | 28.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 189 | $52,164 | $12,771 | 24.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 125 | $49,875 | $12,704 | 25.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 18 | 22 | $12,980 | $2,414 | 18.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 20 | 26 | $12,870 | $2,038 | 15.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 50 | 96 | $41,184 | $11,651 | 28.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 125 | $49,875 | $10,977 | 22.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 97 | $26,895 | $5,934 | 22.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 16 | 16 | $7,920 | $1,260 | 15.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 189 | $75,411 | $16,873 | 22.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 46 | 107 | $45,903 | $13,321 | 29.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 11 | 210 | $83,790 | $19,136 | 22.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 42 | 120 | $51,480 | $11,726 | 22.8% |
About Dr. Neeraj Sinha, MD
Dr. Neeraj Sinha, MD is a Internal Medicine healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891745543.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Neeraj Sinha, MD has received a total of $17,292 in payments from pharmaceutical and medical device companies, with $955.46 received in 2024. These payments were reported across 95 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,420).
As a Medicare-enrolled provider, Sinha has provided services to 372 Medicare beneficiaries, totaling 1,456 services with total Medicare billing of $137,036. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Miami, FL
- Active Since 05/11/2006
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891745543
Products in Payments
- Adempas (Drug) $5,126
- OPSUMIT MACITENTAN (Drug) $3,899
- Cresemba (Drug) $3,503
- CRESEMBA (Drug) $787.50
- FISHER & PAYKEL HEALTHCARE (Device) $488.56
- Circulatory Support (Device) $347.22
- OFEV (Drug) $316.91
- HeartWare HVAD (Device) $218.58
- ACTHAR (Biological) $113.88
- Trifecta GT Tissue Heart Valve (Device) $113.43
- JARDIANCE (Drug) $76.65
- Esbriet (Biological) $76.00
- ProtekDuo Kit (Device) $73.79
- EXALT Model D (Device) $55.94
- Cytogam (Biological) $47.52
- LIVTENCITY (Drug) $35.27
- DUPIXENT (Biological) $27.21
- ACQUIRE (Device) $16.00
- Astagraf XL (Drug) $15.03
- ULTRAFLEX (Device) $10.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Miami
Jay Skyler, Md, MD
Internal Medicine — Payments: $2.9M
Internal Medicine $2.9M
Dr. Lukasz Kwapisz
Internal Medicine — Payments: $800,664
Internal Medicine $800,664
Mark Kutner, Md, MD
Internal Medicine — Payments: $610,516
Internal Medicine $610,516
Dr. Ian Del Conde Pozzi, M.d, M.D
Internal Medicine — Payments: $499,756
Internal Medicine $499,756
Mr. Angel Carrasco, M.d, M.D
Internal Medicine — Payments: $493,362
Internal Medicine $493,362
Dr. Edward Mezerhane, Md, MD
Internal Medicine — Payments: $470,504
Internal Medicine $470,504